Cafepharma Today

June 2 2025 - Gilead's CAR-T cell therapy shows promise in deadly brain cancer
Gilead's CAR-T cell therapy shows promise in deadly brain cancer
Sanofi expands rare immunology portfolio with Blueprint buyout
Moderna's next-gen COVID shot gets FDA backing with some limitations
BioNTech flips its cancer bispecific to BMS for a big profit
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Alnylam Soars To New High On Early Drug Trial Results
Investors.com
Friday, July 12, 2013 - 7:32am
tags:
Alnylam, RNAi, ALN-TTRsc
China Investing Billions In Pharma Sector, Says Lux
Investors.com
Friday, July 12, 2013 - 7:31am
tags:
China
GlaxoSmithKline shares shrug off China bribery probe
Marketwatch
Friday, July 12, 2013 - 7:30am
tags:
GSK, China
Laywer Spars With FDA Over J&J Risperdal Court Documents
Pharmalot
Thursday, July 11, 2013 - 12:10pm
tags:
FDA, JNJ, Risperdal
Cellceutix And Kevetrin Aligning With The Pharmacyclics Growth Curve
Seeking Alpha
Thursday, July 11, 2013 - 12:06pm
tags:
Cellceutix, Kevetrin, Pharmacyclics
The biotech IPO scene turns red hot
Fierce Biotech
Thursday, July 11, 2013 - 11:24am
tags:
biotech, IPOs
BioCryst’s failed flu drug gets another shot at FDA success
Fierce Biotech
Thursday, July 11, 2013 - 11:18am
tags:
FDA, Biocryst, Flu, peramivir
Astex Pharmaceuticals In Focus With Catalyst In The Near Term
Seeking Alpha
Thursday, July 11, 2013 - 11:15am
tags:
Astex, AstraZeneca, Celgene, GSK, JNJ, Novartis, SGI-110, Dacogen
Celgene's Revlimid improves survival in blood cancer patients
Reuters
Thursday, July 11, 2013 - 11:14am
tags:
Celgene, Revlimid, Multiple Myeloma
Former Millennium CEO to head EnVivo
Boston Globe, MA
Thursday, July 11, 2013 - 11:12am
tags:
Millennium Pharmaceutical, EnVivo, Deborah Dunsire
FTC asks for more info for Actavis acquisition
San Francisco Chronicle, CA
Thursday, July 11, 2013 - 11:11am
tags:
Actavis, FTC, M&A, Warner Chilcott
Will This Be the Breakthrough of All Breakthrough Therapy Drugs?
Motley Fool
Thursday, July 11, 2013 - 11:09am
tags:
breakthrough therapies, ibrutinib, Pharmacyclics, JNJ, chronic lymphocytic leukemia
Drug Deal Can Only Help VIVUS So Much
Motley Fool
Thursday, July 11, 2013 - 10:35am
tags:
Vivus, Spedra, Menarini, erectile dysfunction
Intercept OCA likely to qualify for accelerated approval, says Oppenheimer
Yahoo/Fly on the Wall
Thursday, July 11, 2013 - 10:34am
tags:
Intercept Pharma, OCA, primary biliary cirrhosis
Exploding Pipeline Makes BioMarin Attractive Takeover Target
Motley Fool
Thursday, July 11, 2013 - 10:33am
tags:
Biomarin, M&A, Pfizer, Sanofi
Chinese police say Glaxo employees bribed doctors
Yahoo/AP
Thursday, July 11, 2013 - 10:32am
tags:
China, GSK
Rockwell Medical's iron deficiency drug succeeds in trial
Reuters
Thursday, July 11, 2013 - 10:31am
tags:
Rockwell Medical, Iron Deficiency, SFP
The Obesity Drug Battle
Seeking Alpha
Wednesday, July 10, 2013 - 1:56pm
tags:
obesity, Belviq, Arena Pharmaceuticals, Contrave, Orexigen, Vivus, Qsymia, Roche, Xenical, GSK
Are Drugmakers Following Through On Post-Marketing Commitments?
Pharmalot
Wednesday, July 10, 2013 - 1:46pm
tags:
FDA, post-marketing data
How Johnson & Johnson Revamped its Executive Pay Practices
Forbes
Wednesday, July 10, 2013 - 1:31pm
tags:
JNJ, executive pay

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.